1Adehnann M, Wood J, Benzel I, et al. The N-terminal domain of the myelin oligodendrocyte glycoprotein (MOG) induces acute demyclinating experimental auto immune encephalomyelitis in the Lewis rat[J]. J Neuroimmunol, 1995, 63: 17.
2GrandPre T, Nakamura F, Vartanian T, et al. Identification of the Nogo inhibitor of axon regeneration as a reticulon protein [ J ]. Nature, 2000, 403: 439.
3Karnezis T, Mandemakers W, McQualter JL, et al. The neurite outgrowth inhibitor Nogo A is involved in autoimmune-mediated demyelination[ J]. Nat Neurosci, 2004, 7:736.
4Pohnan CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis :2005 revisions to the " McDonald Criteria" [ J ]. Ann Neurol, 2005, 58:840.
5Berger T, Rubner P, Schautzer F, et al. Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event [ J ]. N Eng J Med, 2003, 349 : 139.
6Chen MS, Huber AB, Schwab ME, et al. Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1 [J]. Nature, 2000, 403:434.
7Satoh J, Onoue H, Arima K, et al. Nogo-A and nogo receptor expression in demyelinating lesions of muhipie sclerosis[ J ]. J Neuropathol Exp Neurol, 2005, 64:129.
8Michel M, Fischer U, Meese E. A reticulon gene localized on chromosome 2 encodes a protein with increased autoimmunogenic properties in pilocytic astrocytoma patients [ J ]. Electr J Pathol Histol, 1999, 5:993.
9Egg R, Reindl M, Deisenhammer F, et al. Anti-MOG and anti-MBP antibody subclasses in multiple sclerosis [ J ]. Muh Seler, 2001. 7 :285.
10Kerlero de Rosbo N, Hoffman M, Mendel I, et al. Predominance of the autoimmune response to myelin oligodenrocyte glycoprotein (MOG) in multiple sclerosis: reactivity to the extracellular domain of MOG is directed against three main regions[J]. Eur J lmmunol, 1997, 27:3059.
